Holen Sie sich die Stockscreener-App
2.01
6.35%
0.12
Handel nachbörslich:
2.05
0.04
+1.99%
In 8 Bio Inc Aktie (INAB) Neueste Nachrichten
Risk Off: Will Passage Bio Inc. stock sustain high P E ratiosQuarterly Portfolio Report & Free Technical Confirmation Trade Alerts - BỘ NỘI VỤ
Can Korro Bio Inc. stock surprise with earnings upsideWeekly Profit Summary & Growth Focused Stock Pick Reports - BỘ NỘI VỤ
Nuvation Bio Inc Discontinues NUV-1511 Development - TradingView
Palisade Bio to Present at the Piper Sandler 37th Annual Healthcare Conference - GlobeNewswire
Chmn Hoffman Buys 20,000 ($69.9K) Of Annovis Bio Inc [ANVS] - TradingView
Officer Hanley Sells 200,000 ($1.4M) Of Nuvation Bio Inc [NUVB] - TradingView
Officer Hattersley Files To Sell 369,051 Of Nuvation Bio Inc [NUVB] - TradingView
Officer Liu Files To Sell 20,000 Of Nuvation Bio Inc [NUVB] - TradingView
Officer Liu Sells 30,000 ($148K) Of Nuvation Bio Inc [NUVB] - TradingView
[Form 4] Inmune Bio, Inc. Insider Trading Activity - Stock Titan
[8-K] Inmune Bio, Inc. Reports Material Event | INMB SEC FilingForm 8-K - Stock Titan
Nuvation Bio Inc Publishes Positive Phase 2 Study Results for Safusidenib - TradingView
[8-K] TELA Bio, Inc. Reports Material Event | TELA SEC FilingForm 8-K - Stock Titan
Korro Bio, Inc. (KRRO): RBC Capital Initiates “Sector Perform” Rating with Upside Potential - Stocks Telegraph
[8-K] Instil Bio, Inc. Reports Material Event | TIL SEC FilingForm 8-K - Stock Titan
[8-K] Annovis Bio, Inc. Reports Material Event | ANVS SEC FilingForm 8-K - Stock Titan
[S-8] PALISADE BIO, INC. Employee Benefit Plan Registration | PALI SEC FilingForm S-8 - Stock Titan
[8-K] KALA BIO, Inc. Reports Material Event | KALA SEC FilingForm 8-K - Stock Titan
[Form 4] Annovis Bio, Inc. Insider Trading Activity - Stock Titan
Inmune Bio, Inc. Announces Key Developments in Clinical Programs - TradingView
[8-K] Passage BIO, Inc. Reports Material Event | PASG SEC FilingForm 8-K - Stock Titan
[8-K] Cabaletta Bio, Inc. Reports Material Event | CABA SEC FilingForm 8-K - Stock Titan
Belite Bio Inc expected to post a loss of 49 cents a shareEarnings Preview - TradingView
KALA BIO Inc expected to post a loss of $1.45 a shareEarnings Preview - TradingView
IN8bio Reports Third Quarter 2025 Financial Results and Recent Business Highlights - GlobeNewswire Inc.
[8-K] Climb Bio, Inc. Reports Material Event | CLYM SEC FilingForm 8-K - Stock Titan
[8-K] Gossamer Bio, Inc. Reports Material Event | GOSS SEC FilingForm 8-K - Stock Titan
Gossamer Bio Inc reports results for the quarter ended September 30Earnings Summary - TradingView
[PRE 14A] Adicet Bio, Inc. Preliminary Proxy Statement - Stock Titan
[8-K] Adicet Bio, Inc. Reports Material Event | ACET SEC FilingForm 8-K - Stock Titan
[8-K] ImmunityBio, Inc. Reports Material Event | IBRX SEC FilingForm 8-K - Stock Titan
TELA Bio to Announce Third Quarter 2025 Financial Results - GlobeNewswire
Cabaletta Bio (Nasdaq: CABA) offers webcasts across Nov–Dec conferences; 30-day replays - Stock Titan
Gossamer Bio Inc expected to post a loss of 19 cents a shareEarnings Preview - TradingView
[Form 4] TELA Bio, Inc. Insider Trading Activity - Stock Titan
[Form 3] TELA Bio, Inc. Initial Statement of Beneficial Ownership - Stock Titan
Cabaletta Bio, Inc. (NASDAQ:CABA) Short Interest Up 85.8% in October - Defense World
[8-K] Protagenic Therapeutics, Inc.new Reports Material Event | PTIX SEC FilingForm 8-K - Stock Titan
Nuvation Bio Inc (NUVB) Q3 2025: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
Cabaletta Bio, Inc. Updates on Rese-cel Clinical Trials and FDA Alignment - TradingView
ANVS prices registered direct; directors buy 1.07M shares at $2.05 - Stock Titan
INMB to discuss Q3 2025 results on Oct 30, 4:30 p.m. ET - Stock Titan
Tourmaline Bio Announces Board and Executive Resignations Following Merger - TradingView
[8-K] Tourmaline Bio, Inc. Reports Material Event | TRML SEC FilingForm 8-K - Stock Titan
Why Nuvation Bio Inc. stock is a must watch in 2025Trade Entry Report & Long-Term Safe Investment Ideas - fcp.pa.gov.br
Cabaletta Bio, Inc. Presents Clinical Data and Updates at ACR Convergence 2025 - TradingView
INmune Bio (NASDAQ: INMB) schedules results call for 4:30 PM ET on Oct 30 - Stock Titan
[8-K] PALISADE BIO, INC. Reports Material Event | PALI SEC FilingForm 8-K - Stock Titan
Q32 Bio Inc Completes Enrollment in SIGNAL-AA Phase 2a Trial - TradingView
[8-K] bioAffinity Technologies, Inc. Reports Material Event | BIAF SEC FilingForm 8-K - Stock Titan
PALI annual meeting: directors elected, auditor ratified, split approved - Stock Titan
Stop Loss: Why Nuvation Bio Inc. stock is popular among millennials2025 Sector Review & Breakout Confirmation Alerts - Trung tâm Dự báo KTTV quốc gia
Samsung to invest $110 mn in Grail to bring early-cancer test to Asia - KED Global
Climb Bio Publishes Long-Term Data on Budoprutug - TradingView
Climb Bio to Present Data at American Society of Nephrology (ASN) Kidney Week 2025 - Stock Titan
0.76%
2.16%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):